Cargando…
MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy
Objective: Transcutaneous Magnetic Stimulation (TCMS) is reported to be an effective treatment in multiple neurologic conditions such as migraine headaches, lower back pain, and post-traumatic peripheral neuropathic pain(1-3). The efficacy and safety of TCMS for diabetic peripheral neuropathy is not...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209259/ http://dx.doi.org/10.1210/jendso/bvaa046.2166 |
_version_ | 1783531036433448960 |
---|---|
author | Satyarengga, Medha Munir, Kashif M |
author_facet | Satyarengga, Medha Munir, Kashif M |
author_sort | Satyarengga, Medha |
collection | PubMed |
description | Objective: Transcutaneous Magnetic Stimulation (TCMS) is reported to be an effective treatment in multiple neurologic conditions such as migraine headaches, lower back pain, and post-traumatic peripheral neuropathic pain(1-3). The efficacy and safety of TCMS for diabetic peripheral neuropathy is not known. We evaluated whether TCMS is effective and safe in patients with diabetic peripheral neuropathy. Method: Eight patients with a previous diagnosis of diabetic peripheral neuropathy and baseline numerical pain-rating scale (NPRS) of 5 or greater in both feet were enrolled. NPRS scale was set from 0 to 10, 0 represents no pain and 10 representing the most severe pain. Each patient was treated with a single session of TCMS applied first on the plantar then the dorsal surface of both feet. Magnetic pulses (1.2 Tesla) were delivered every 6 seconds for 5 minutes in each foot on the plantar and dorsal surfaces, respectively. NPRS was repeated post-treatment over the course of 28-days follow-up period. Results: The mean baseline NPRS was 5.8 (± 1.0). Immediately post-treatment, mean NPRS improved to 1.3 (± 1.9), a 77.7 (± 36.5) % decrease. Mean NPRS at 7 and 28 days of follow-up was 2.9 (± 2.8) and 4.1 (± 3.3), respectively. These represent a 53.2(± 42.4) % improvement at 7 days and 30.5(±52.4) % improvement at 28 days of follow-up compared to baseline NPRS. None of the patients reported significant discomfort during the treatment, and no major side effects were observed during the study period. Conclusion: In this pilot study of patients with diabetic peripheral neuropathy, TCMS appears to be a safe and effective alternative in providing temporary pain relief. Longer and more frequent treatment sessions need to be explored to see if these can increase the effective duration. References: 1. Barker AT, Shields K. Transcranial Magnetic Stimulation: Basic Principles and Clinical Applications in Migraine. Headache. 2017 Mar;57(3):517-524. 2. Leung A, Fallah A, Shukla S. Transcutaneous Magnetic Stimulation (tMS) in Alleviating Post-Traumatic Peripheral Neuropathic Pain States: A Case Series. Pain Medicine. 2014 Jul; 15(7): 1196-1199. 3. Lim YH, Song JM, Choi EH, Lee JW. Effects of Repetitive Peripheral Magnetic Stimulation on Patients with Acute Low Back Pain: A Pilot Study. Ann Rehabil Med. 2018 Apr; 42(2): 229-238. |
format | Online Article Text |
id | pubmed-7209259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72092592020-05-13 MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy Satyarengga, Medha Munir, Kashif M J Endocr Soc Diabetes Mellitus and Glucose Metabolism Objective: Transcutaneous Magnetic Stimulation (TCMS) is reported to be an effective treatment in multiple neurologic conditions such as migraine headaches, lower back pain, and post-traumatic peripheral neuropathic pain(1-3). The efficacy and safety of TCMS for diabetic peripheral neuropathy is not known. We evaluated whether TCMS is effective and safe in patients with diabetic peripheral neuropathy. Method: Eight patients with a previous diagnosis of diabetic peripheral neuropathy and baseline numerical pain-rating scale (NPRS) of 5 or greater in both feet were enrolled. NPRS scale was set from 0 to 10, 0 represents no pain and 10 representing the most severe pain. Each patient was treated with a single session of TCMS applied first on the plantar then the dorsal surface of both feet. Magnetic pulses (1.2 Tesla) were delivered every 6 seconds for 5 minutes in each foot on the plantar and dorsal surfaces, respectively. NPRS was repeated post-treatment over the course of 28-days follow-up period. Results: The mean baseline NPRS was 5.8 (± 1.0). Immediately post-treatment, mean NPRS improved to 1.3 (± 1.9), a 77.7 (± 36.5) % decrease. Mean NPRS at 7 and 28 days of follow-up was 2.9 (± 2.8) and 4.1 (± 3.3), respectively. These represent a 53.2(± 42.4) % improvement at 7 days and 30.5(±52.4) % improvement at 28 days of follow-up compared to baseline NPRS. None of the patients reported significant discomfort during the treatment, and no major side effects were observed during the study period. Conclusion: In this pilot study of patients with diabetic peripheral neuropathy, TCMS appears to be a safe and effective alternative in providing temporary pain relief. Longer and more frequent treatment sessions need to be explored to see if these can increase the effective duration. References: 1. Barker AT, Shields K. Transcranial Magnetic Stimulation: Basic Principles and Clinical Applications in Migraine. Headache. 2017 Mar;57(3):517-524. 2. Leung A, Fallah A, Shukla S. Transcutaneous Magnetic Stimulation (tMS) in Alleviating Post-Traumatic Peripheral Neuropathic Pain States: A Case Series. Pain Medicine. 2014 Jul; 15(7): 1196-1199. 3. Lim YH, Song JM, Choi EH, Lee JW. Effects of Repetitive Peripheral Magnetic Stimulation on Patients with Acute Low Back Pain: A Pilot Study. Ann Rehabil Med. 2018 Apr; 42(2): 229-238. Oxford University Press 2020-05-08 /pmc/articles/PMC7209259/ http://dx.doi.org/10.1210/jendso/bvaa046.2166 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Diabetes Mellitus and Glucose Metabolism Satyarengga, Medha Munir, Kashif M MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy |
title | MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy |
title_full | MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy |
title_fullStr | MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy |
title_full_unstemmed | MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy |
title_short | MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy |
title_sort | mon-lb109 transcutaneous magnetic stimulation: a novel treatment of diabetic peripheral neuropathy |
topic | Diabetes Mellitus and Glucose Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209259/ http://dx.doi.org/10.1210/jendso/bvaa046.2166 |
work_keys_str_mv | AT satyarenggamedha monlb109transcutaneousmagneticstimulationanoveltreatmentofdiabeticperipheralneuropathy AT munirkashifm monlb109transcutaneousmagneticstimulationanoveltreatmentofdiabeticperipheralneuropathy |